Li Jing, Wen Wen, Zhao Shu, Wang Jingxuan, Chen Jingyu, Wang Yanrong, Zhang Qingyuan
Department of Internal Medicine, The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.
Department of Anesthesia, The Third Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China.
Onco Targets Ther. 2015 Jun 15;8:1471-82. doi: 10.2147/OTT.S84687. eCollection 2015.
HOX transcript antisense intergenic RNA (HOTAIR), a long non-coding RNA transcribed from the antisense strand of the HOXC gene locus, has been shown to be overexpressed in various carcinomas and is thought to be an indicator of poor prognosis. Recently, HOTAIR was found to be an estrogen-responsive gene. We therefore conducted a meta-analysis to systematically summarize and clarify the association between HOTAIR expression and prognosis in the four main estrogen-dependent tumors.
A systematic search of studies that examined the association and prognostic impact of HOTAIR in four of the main estrogen-dependent tumors was conducted in PubMed and Embase. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated to pool the effect size.
A total of 1,200 patients from eight eligible studies were included. The current study found an association between HOTAIR expression and overall survival (OS) in four estrogen-dependent tumor types (HR, 1.99; 95% CI: 1.02-3.90; P Heterogeneity=0.001). Subgroup analyses indicated that high HOTAIR expression appeared to be a potential prognostic biomarker in non-breast cancer patients (HR, 2.72; 95% CI: 1.65-4.48). There was also an increased risk in Asian populations (HR, 2.55; 95% CI: 1.62-4.00) compared with Caucasian populations (HR, 1.19; 95% CI: 0.16-8.83) and in patients without preoperative treatment (HR, 2.55; 95% CI: 1.62-4.00) compared with patients with preoperative treatment (HR, 1.19; 95% CI: 0.16-8.83). In addition, the HRs of patients with high HOTAIR expression for metastasis-free survival (MFS), relapse-free survival (RFS), and disease-free survival (DFS) were 2.30 (P=0.120), 1.39 (P=0.000), and 2.53 (P=0.714), respectively, but there were insufficient data to fully confirm these associations.
HOTAIR may be a predictor of poor prognosis in four of the main estrogen-dependent tumors, especially in cervical, ovarian, and endometrial cancer patients without preoperative treatment in Asian populations. It is important to note that the prognostic value of HOTAIR in MFS, RFS, and DFS should be interpreted with caution due to the limited sample size and sample heterogeneity. Well-designed and larger-scale studies are needed to validate our findings.
HOX转录本反义基因间RNA(HOTAIR)是一种从HOXC基因座反义链转录的长链非编码RNA,已证实在多种癌症中过表达,并被认为是预后不良的指标。最近,发现HOTAIR是一种雌激素反应性基因。因此,我们进行了一项荟萃分析,以系统地总结和阐明HOTAIR表达与四种主要雌激素依赖性肿瘤预后之间的关联。
在PubMed和Embase中系统检索研究HOTAIR在四种主要雌激素依赖性肿瘤中的关联及预后影响的研究。计算风险比(HR)和95%置信区间(95%CI)以汇总效应量。
纳入了来自八项符合条件研究的共1200例患者。当前研究发现HOTAIR表达与四种雌激素依赖性肿瘤类型的总生存期(OS)之间存在关联(HR,1.99;95%CI:1.02 - 3.90;P异质性 = 0.001)。亚组分析表明,HOTAIR高表达似乎是非乳腺癌患者的潜在预后生物标志物(HR,2.72;95%CI:1.65 - 4.48)。与白种人群(HR,1.19;95%CI:0.16 - 8.83)相比,亚洲人群中风险也增加(HR,2.55;95%CI:1.62 - 4.00),且与术前接受治疗的患者(HR,1.19;95%CI:0.16 - 8.83)相比,未接受术前治疗的患者中风险增加(HR,2.55;95%CI:1.62 - 4.00)。此外,HOTAIR高表达患者的无转移生存期(MFS)、无复发生存期(RFS)和无病生存期(DFS)的HR分别为2.30(P = 0.120)、1.39(P = 0.000)和2.53(P = 0.714),但数据不足以充分证实这些关联。
HOTAIR可能是四种主要雌激素依赖性肿瘤预后不良的预测指标,尤其是在亚洲人群中未接受术前治疗的宫颈癌、卵巢癌和子宫内膜癌患者中。需要注意的是,由于样本量有限和样本异质性,HOTAIR在MFS、RFS和DFS中的预后价值应谨慎解读。需要设计良好且规模更大的研究来验证我们的发现。